Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1267549.RA5IXv84RnAU_8_6538G0qd6bwK5kjGgTg7W5nf0J6Lfw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1267549.RA5IXv84RnAU_8_6538G0qd6bwK5kjGgTg7W5nf0J6Lfw130_assertion type Assertion NP1267549.RA5IXv84RnAU_8_6538G0qd6bwK5kjGgTg7W5nf0J6Lfw130_head.
- NP1267549.RA5IXv84RnAU_8_6538G0qd6bwK5kjGgTg7W5nf0J6Lfw130_assertion description "[Variants in triggering receptor expressed on myeloid cells 2 (TREM2) confer high risk for Alzheimer's disease (AD) and other neurodegenerative diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267549.RA5IXv84RnAU_8_6538G0qd6bwK5kjGgTg7W5nf0J6Lfw130_provenance.
- NP1267549.RA5IXv84RnAU_8_6538G0qd6bwK5kjGgTg7W5nf0J6Lfw130_assertion evidence source_evidence_literature NP1267549.RA5IXv84RnAU_8_6538G0qd6bwK5kjGgTg7W5nf0J6Lfw130_provenance.
- NP1267549.RA5IXv84RnAU_8_6538G0qd6bwK5kjGgTg7W5nf0J6Lfw130_assertion SIO_000772 25732305 NP1267549.RA5IXv84RnAU_8_6538G0qd6bwK5kjGgTg7W5nf0J6Lfw130_provenance.
- NP1267549.RA5IXv84RnAU_8_6538G0qd6bwK5kjGgTg7W5nf0J6Lfw130_assertion wasDerivedFrom befree-2016 NP1267549.RA5IXv84RnAU_8_6538G0qd6bwK5kjGgTg7W5nf0J6Lfw130_provenance.
- NP1267549.RA5IXv84RnAU_8_6538G0qd6bwK5kjGgTg7W5nf0J6Lfw130_assertion wasGeneratedBy ECO_0000203 NP1267549.RA5IXv84RnAU_8_6538G0qd6bwK5kjGgTg7W5nf0J6Lfw130_provenance.